Phibro Animal Health Corporation (NASDAQ:PAHC) — Market Cap & Net Worth

$671.46 Million USD · Rank #10981

Market Cap & Net Worth: Phibro Animal Health Corporation (PAHC)

Phibro Animal Health Corporation (NASDAQ:PAHC) has a market capitalization of $671.46 Million ($671.46 Million) as of June 17, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #10981 globally and #2801 in its home market, demonstrating a 0.35% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Phibro Animal Health Corporation's stock price $31.87 by its total outstanding shares 21068682 (21.07 Million). Review Phibro Animal Health Corporation debt and liabilities to assess the company's total debt and financial obligations.

Phibro Animal Health Corporation Market Cap History: 2015 to 2026

Phibro Animal Health Corporation's market capitalization history from 2015 to 2026. Data shows growth from $522.93 Million to $671.46 Million (1.46% CAGR).

Index Memberships

Phibro Animal Health Corporation is a constituent of 4 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
NASDAQ Health Care IXHC	$2.43 Trillion	0.03%	#292 of 976
NASDAQ Composite IXIC	$41.27 Trillion	0.00%	#1097 of 3165
NASDAQ Biotechnology NBI	$1.70 Trillion	0.04%	#172 of 263
S&P Small-Cap 600 Index SML	$1.65 Trillion	0.03%	#525 of 602

Weight: Phibro Animal Health Corporation's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Phibro Animal Health Corporation Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Phibro Animal Health Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

0.61x

Phibro Animal Health Corporation's market cap is 0.61 times its annual revenue

Industry average: 0.53x Higher than industry average

Latest Price to Earnings (P/E) Ratio

16.31x

Phibro Animal Health Corporation's market cap is 16.31 times its annual earnings

Industry average: 0.02x Higher than industry average

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2016	$516.88 Million	$751.50 Million	$82.70 Million	0.69x	6.25x
2017	$598.27 Million	$764.30 Million	$64.60 Million	0.78x	9.26x
2018	$580.31 Million	$820.00 Million	$64.90 Million	0.71x	8.94x
2019	$456.68 Million	$828.00 Million	$54.70 Million	0.55x	8.35x
2020	$364.95 Million	$800.35 Million	$33.55 Million	0.46x	10.88x
2021	$391.51 Million	$833.35 Million	$54.38 Million	0.47x	7.20x
2022	$264.96 Million	$942.26 Million	$49.17 Million	0.28x	5.39x
2023	$237.50 Million	$977.89 Million	$32.61 Million	0.24x	7.28x
2024	$442.44 Million	$1.02 Billion	$2.42 Million	0.43x	183.13x
2025	$787.13 Million	$1.30 Billion	$48.26 Million	0.61x	16.31x

Competitor Companies of PAHC by Market Capitalization

Companies near Phibro Animal Health Corporation in the global market cap rankings as of June 17, 2026.

Key companies related to Phibro Animal Health Corporation by market ranking:

Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #513 globally with a market cap of $52.60 Billion USD.
GALDERMA GROUP AG (NYSE:GALDY): Ranked #561 globally with a market cap of $48.78 Billion USD.
Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #624 globally with a market cap of $44.20 Billion USD ( CN¥302.05 Billion CNY).
Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #635 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#513	Takeda Pharmaceutical Co Ltd ADR	NYSE:TAK	$52.60 Billion	$16.65
#561	GALDERMA GROUP AG	NYSE:GALDY	$48.78 Billion	$43.22
#624	Jiangsu Hengrui Medicine Co Ltd	SHG:600276	$44.20 Billion	CN¥47.35
#635	Takeda Pharmaceutical Company Limited	F:TKDA	$43.60 Billion	€13.60

Phibro Animal Health Corporation Historical Marketcap From 2015 to 2026

Between 2015 and today, Phibro Animal Health Corporation's market cap moved from $522.93 Million to $ 671.46 Million, with a yearly change of 1.46%.

Year	Market Cap	Change (%)
2026	$671.46 Million	-14.69%
2025	$787.13 Million	+77.90%
2024	$442.44 Million	+86.29%
2023	$237.50 Million	-10.36%
2022	$264.96 Million	-32.32%
2021	$391.51 Million	+7.28%
2020	$364.95 Million	-20.09%
2019	$456.68 Million	-21.30%
2018	$580.31 Million	-3.00%
2017	$598.27 Million	+15.75%
2016	$516.88 Million	-1.16%
2015	$522.93 Million	--

End of Day Market Cap According to Different Sources

On Jun 17th, 2026 the market cap of Phibro Animal Health Corporation was reported to be:

Source	Market Cap
Yahoo Finance	$671.46 Million USD
MoneyControl	$671.46 Million USD
MarketWatch	$671.46 Million USD
marketcap.company	$671.46 Million USD
Reuters	$671.46 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Phibro Animal Health Corporation

NASDAQ:PAHC USA Drug Manufacturers - Specialty & Generic

Market Cap

$671.46 Million

Market Cap Rank

#10981 Global

#2801 in USA

Share Price

$31.87

Change (1 day)

-1.27%

52-Week Range

$23.88 - $59.58

All Time High

$59.58